The study evaluated multiple RNA‐based NGS panels for the identification of NTRK fusions, including TPM3‐NTRK1, in various cancer samples, including lung adenocarcinoma and papillary thyroid carcinoma (PTC). This evidence concerns the gene NTRK1 and lung adenocarcinoma.